Aug 3 |
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
|
Aug 2 |
UniQure to cut 65% of workforce, or 300 jobs, in major restructuring
|
Aug 2 |
uniQure GAAP EPS of -$1.16, revenue of $11.1M
|
Aug 1 |
UniQure restructuring to claim 300 jobs
|
Aug 1 |
UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 1 |
UniQure: Q2 Earnings Snapshot
|
Aug 1 |
uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
|
Jul 26 |
Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High?
|
Jul 23 |
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen
|
Jul 12 |
uniQure’s shares soar on positive data for Huntington’s gene therapy
|